BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 8, 2020
View Archived Issues
Phase I study of hCT-MSC in neonates with hypoxic-ischemic encephalopathy
Read More
Design and characterization of novel topoisomerase II poisons with improved drug-like profile
Read More
New D peptide blocking TIGIT/PVR binding for cancer immunotherapy even in anti-PD-1-resistant tumors
Read More
Elixirgen advances COVID-19 vaccine candidate EXG-5003 following pre-IND meeting with FDA
Read More
Phase II data for tomivosertib added to continued checkpoint inhibitor therapy
Read More
Bermekimab + nanoliposomal irinotecan and 5-FU/FA shows efficacy in refractory pancreatic cancer
Read More
Antiviral vaccine protects against myocarditis, diabetes
Read More
First healthy volunteer dosed in phase I trial of ARCT-810
Read More
FDA clears IND application for BX-U001 in rheumatoid arthritis
Read More
TQ-B3525 demonstrates safety and promising antitumor activity in phase I trial
Read More
Series B financing extension to support Artax's development of AX-158 for autoimmune diseases
Read More
Phase I data presented for anti-EGFR ADC MRG-003 in relapsed/refractory solid tumors
Read More
Survival improved with apatinib in Chinese patients with pretreated hepatocellular carcinoma
Read More
BeiGene patents new MAP4K1 inhibitors
Read More
TES Pharma describes ACMSD inhibitors
Read More
Qilu Regor Therapeutics identifies GLP-1 receptor agonists
Read More
Inception IBD discloses new VNN1 inhibitors
Read More
Sleep deprivation kills through punch to the gut
Read More
New arginase inhibitors presented by Arcus Biosciences
Read More
SARS-CoV-2 neutralizing antibody JS-016 begins phase I study in China
Read More
Bavarian Nordic reports first-in-human data on equine encephalitis virus vaccine MVA-BN WEV
Read More
Lumosa initiates phase I/II study of LT-5001 for uremic pruritus in hemodialysis patients
Read More
Enrollment underway in phase III trial of MBG-453 for MDS and CMML-2
Read More
Mabspace begins first-in-human study of TST-001 in advanced or metastatic solid tumors
Read More
FibroGen announces new trials of pamrevlumab for COVID-19
Read More
